Activity Overview
This educational activity is an archive of the live presentation held on May 29, 2026.
For more information about this educational activity, the faculty,
and disclosures, please click here.
Target Audience
This
educational activity is directed toward medical oncologists, NPs/PAs, nurses,
pharmacists, and other HCPs involved in the treatment and management of
myelofibrosis.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate recent clinical trial data for new and emerging strategies to treat patients with MF
- Integrate appropriate evidence-based treatment strategies for patients with newly diagnosed and previously treated MF
- Examine best practices and clinical considerations for supportive care in MF
- Describe strategies to identify and manage toxicities associated with treatments for MF
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
